Amarin Corp Plc (AMRN)

[biowreck]

$8-$12billion. If they’re smart and fast. If BP hadn’t stepped up to make an offer prior to the ruling, as was pointed out so many times before...why would they do that now? Why would they want to take on a company handicapped by an appeals process that could be ongoing for years? Seems an injunction would provide certainty as to keeping generics at bay, but that may only cover a couple years, and the anda filings taking a couple years for approval as well as launch seems like a reach when it comes to convincing BP there’s a great risk reward here.

Just thinking out loud here, as I’m weighing my options like so many here are...